✦ LIBER ✦

417 Human biotransformation of olaparib (AZD2281) an oral poly(ADP-ribose) polymerase (PARP) inhibitor

✍ Scribed by J. Clarkson-Jones; C. Page; S. Sarda; H. Swaisland

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and tolerability of the poly(ADP-

✍ Jens Samol, Malcolm Ranson, Edwina Scott, Euan Macpherson, James Carmichael, Ann 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 215 KB

A Phase 1 trial of the poly(ADP-ribose)

✍ Liu, Joyce F.; Tolaney, Sara M.; Birrer, Michael; Fleming, Gini F.; Buss, Mary K 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 580 KB

217 Testing of a poly(ADP-ribose) polyme

✍ A.M. Halldorsdottir; L. Vidarsdottir; O.A. Stefansson; H. Bjarnason; S.K. Bodvar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Oral poly(ADP-ribose) polymerase inhibit

✍ Andrew Tutt; Mark Robson; Judy E Garber; Susan M Domchek; M William Audeh; Jeffr 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 594 KB

Oral poly(ADP-ribose) polymerase inhibit

✍ M William Audeh; James Carmichael; Richard T Penson; Michael Friedlander; Bethan 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 268 KB

Oral poly(ADP-ribose) polymerase inhibit

✍ Gelmon, K.A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 107 KB